Cargando…

Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis

Following infection with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), most human hosts are able to contain the infection and avoid progression to active TB disease through expression of a balanced, homeostatic immune response. Proinflammatory mechanisms aiming to kill, slow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krug, Stefanie, Parveen, Sadiya, Bishai, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089478/ https://www.ncbi.nlm.nih.gov/pubmed/33953722 http://dx.doi.org/10.3389/fimmu.2021.660916

Ejemplares similares

Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
por: Ndlovu, Hlumani, et al.
Publicado: (2016)

Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
por: Kim, Jae-Sung, et al.
Publicado: (2020)

Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis
por: Brown, Robert E., et al.
Publicado: (2017)

Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
por: Abreu, Rodrigo, et al.
Publicado: (2020)

The Troika Host–Pathogen–Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes
por: Bastos, Helder Novais, et al.
Publicado: (2018)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis
por: Nienaber, Arista, et al.
Publicado: (2021)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
por: Guler, Reto, et al.
Publicado: (2021)

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?
por: Dutta, Noton K., et al.
Publicado: (2020)

Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2017)

Modulation of innate immunity in airway epithelium for host-directed therapy
por: Myszor, Iwona T., et al.
Publicado: (2023)

Host-directed therapy for bacterial infections -Modulation of the phagolysosome pathway-
por: Taya, Toshihiko, et al.
Publicado: (2023)

Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
por: Shim, Dahee, et al.
Publicado: (2020)

Corrigendum: Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
por: Shim, Dahee, et al.
Publicado: (2020)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2021)

Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
por: Palucci, Ivana, et al.
Publicado: (2020)

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
por: Kroesen, Vera M., et al.
Publicado: (2017)

Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1β Production in Dendritic Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis
por: Khan, Nargis, et al.
Publicado: (2016)

Host-Directed Therapies for Cutaneous Leishmaniasis
por: Novais, Fernanda O., et al.
Publicado: (2021)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections
por: Aguilera, Elizabeth R., et al.
Publicado: (2020)

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Host-Directed Therapies for Tuberculosis
por: Jeong, Eui-Kwon, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex
por: Crilly, Nathan P., et al.
Publicado: (2021)

Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2016)

An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
por: Karanika, Styliani, et al.
Publicado: (2022)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation
por: Hasturk, Hatice, et al.
Publicado: (2021)

Editorial: Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance
por: Nisini, Roberto, et al.
Publicado: (2020)

Mycobacterial Dormancy Systems and Host Responses in Tuberculosis
por: Peddireddy, Vidyullatha, et al.
Publicado: (2017)

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
por: Bullen, C. Korin, et al.
Publicado: (2023)

Potentials of Host-Directed Therapies in Tuberculosis Management
por: Dara, Yash, et al.
Publicado: (2019)

Manipulation of autophagy for host-directed tuberculosis therapy
por: Gina, P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s7ljsb9rfsnvnkdf4b6ccko425